Showing results (181-190 of 3,162) with videos related to

Sort By:
Pageof 317
Translational Oncology|March 7, 2025
Inflammasomes in lymphocytes as therapeutic targetsZarema Albakova
Translational Oncology|April 8, 2025
Tumor-derived immunoglobulin-like transcript 3 inhibition reshapes the immunosuppressive tumor microenvironment and potentiates programmed cell death ligand 1 blockade immunotherapy in lung adenocarcinomaLeirong Wang, Qing Li, Yanxin Sun, et al.
Translational Oncology|April 5, 2025
Next-generation sequencing in early-stage multiple primary lung cancer: The prognostic significance of genomic accumulation status and BCL2L11delMu-Ting Wang, Chen-Hui Ni, Yan-Qi Lu, et al.
Translational Oncology|March 11, 2025
Tumor-stroma proportion is associated with increased M2 macrophage abundance and predicts the resistance to immune checkpoint blockade in breast cancerYincheng Liu, Ningyi Xue, Yuelin Liu, et al.
Translational Oncology|December 18, 2024
Design of a humanized CD40 agonist antibody with specific properties using AlphaFold2 and development of an anti-PD-L1/CD40 bispecific antibody for cancer immunotherapyKun Du, He Huang
Translational Oncology|December 4, 2024
Indirect targeting of MYC and direct targeting in combination with chemotherapies are more effective than direct mono-targeting in triple negative breast cancerNegesse Mekonnen, Hobin Yang, Nirmal Rajasekaran, et al.
Translational Oncology|December 2, 2024
Patient-derived tumor organoids: A preclinical platform for personalized cancer therapySebastien Taurin, Reem Alzahrani, Sahar Aloraibi, et al.
Translational Oncology|December 1, 2024
Molecular profiling of head and neck squamous cell carcinomas in North-eastern Italy identifies possible tumour cell vulnerabilitiesMonica Schiappacassi, Riccardo Spizzo, Jerry Polesel, et al.
Translational Oncology|December 17, 2024
Cellular heterogeneity and cytokine signatures in acute myeloid leukemia: A novel prognostic modelJinxia Cao, Bin Hu, Tianqi Li, et al.
Translational Oncology|December 11, 2024
Composition analysis and mechanism of Guizhi Fuling capsule in anti-cisplatin-resistant ovarian cancerLei Dou, Yan Yan, Enting Lu, et al.
Pageof 317